Xenograft models were not involved to analyze the influence of RUNX3/GALNT6/MUC1 axis on HCC progression in vivo, and clinical samples were not obtained for certifying the correlation between GALNT6 expression and pathological features. The gene discussed is GALNT6; the disease is hepatocellular carcinoma.